{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T23:26:53Z","timestamp":1773876413881,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T00:00:00Z","timestamp":1763856000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1195460"],"award-info":[{"award-number":["GNT1195460"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT2025939"],"award-info":[{"award-number":["GNT2025939"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Patient Education and Counseling"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.pec.2025.109432","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T16:06:17Z","timestamp":1763827577000},"page":"109432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Patients\u2019 attitudes towards deprescribing disease modifying anti-rheumatic drugs in rheumatoid arthritis"],"prefix":"10.1016","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4527-9872","authenticated-orcid":false,"given":"Lauren","family":"Fraser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Wiese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagham","family":"Ailabouni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa Kalisch","family":"Ellett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3294-7883","authenticated-orcid":false,"given":"Caroline","family":"Sirois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7304-670X","authenticated-orcid":false,"given":"William","family":"Berthelot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna M.","family":"Proudman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leah","family":"McWilliams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1405-999X","authenticated-orcid":false,"given":"Emily","family":"Reeve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.pec.2025.109432_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update","volume":"82","author":"Smolen","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.pec.2025.109432_bib2","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/art.41752","article-title":"2021 American college of rheumatology guideline for the treatment of rheumatoid arthritis","volume":"73","author":"Fraenkel","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"10.1016\/j.pec.2025.109432_bib3","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1007\/s10067-023-06646-0","article-title":"Prevalence and factors associated with polypharmacy among patients with rheumatoid arthritis: a single-centre, cross-sectional study","volume":"42","author":"Miyake","year":"2023","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.pec.2025.109432_bib4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4212\/cjhp.v66i3.1261","article-title":"Deprescribing: what is it and what does the evidence tell us?","volume":"66","author":"Thompson","year":"2013","journal-title":"Can J Hosp Pharm"},{"issue":"6","key":"10.1016\/j.pec.2025.109432_bib5","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/bcp.12732","article-title":"A systematic review of the emerging definition of \u2018deprescribing\u2019with network analysis: implications for future research and clinical practice","volume":"80","author":"Reeve","year":"2015","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"10.1016\/j.pec.2025.109432_bib6","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1093\/rheumatology\/kez037","article-title":"Polypharmacy is associated with treatment response and serious adverse events: results from the British society for rheumatology biologics register for rheumatoid arthritis","volume":"58","author":"Bechman","year":"2019","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.pec.2025.109432_bib7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11096-013-9871-z","article-title":"Benefits of deprescribing on patients\u2019 adherence to medications","volume":"36","author":"Reeve","year":"2014","journal-title":"Int J Clin Pharm"},{"issue":"5","key":"10.1016\/j.pec.2025.109432_bib8","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jamainternmed.2015.0324","article-title":"Reducing inappropriate polypharmacy: the process of deprescribing","volume":"175","author":"Scott","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"3","key":"10.1016\/j.pec.2025.109432_bib9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/17512433.2020.1730812","article-title":"A systems approach to identifying the challenges of implementing deprescribing in older adults across different health-care settings and countries: a narrative review","volume":"13","author":"Sawan","year":"2020","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.pec.2025.109432_bib10","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/bcp.12386","article-title":"Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process","volume":"78","author":"Reeve","year":"2014","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"10.1016\/j.pec.2025.109432_bib11","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s40266-016-0410-1","article-title":"Development and validation of the revised patients\u2019 attitudes towards deprescribing (rPATD) questionnaire: versions for older adults and caregivers","volume":"33","author":"Reeve","year":"2016","journal-title":"Drugs Aging"},{"key":"10.1016\/j.pec.2025.109432_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11096-012-9704-5","article-title":"Development and validation of the patients\u2019 attitudes towards deprescribing (PATD) questionnaire","volume":"35","author":"Reeve","year":"2013","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"10.1016\/j.pec.2025.109432_bib13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s12888-025-06717-3","article-title":"Attitudes of Australian patients receiving inpatient mental health care towards deprescribing: a cross-sectional survey","volume":"25","author":"Law","year":"2025","journal-title":"BMC Psychiatry"},{"issue":"10","key":"10.1016\/j.pec.2025.109432_bib14","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.sapharm.2020.02.014","article-title":"Attitudes toward deprescribing in a middle-aged health disparities population","volume":"16","author":"Martinez","year":"2020","journal-title":"Res Soc Adm Pharm"},{"issue":"11","key":"10.1016\/j.pec.2025.109432_bib15","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.sapharm.2023.07.011","article-title":"Translation, cultural adaptation and validation of the revised patients\u2019 attitudes towards deprescribing (rPATD) questionnaire in Romanian older adults","volume":"19","author":"Bucsa","year":"2023","journal-title":"Res Soc Adm Pharm"},{"issue":"1","key":"10.1016\/j.pec.2025.109432_bib16","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afac335","article-title":"Willingness of older people living with dementia and mild cognitive impairment and their caregivers to have medications deprescribed","volume":"52","author":"Reeve","year":"2023","journal-title":"Age Ageing"},{"issue":"5","key":"10.1016\/j.pec.2025.109432_bib17","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1093\/gerona\/glab222","article-title":"Consumer attitudes towards deprescribing: a systematic review and meta-analysis","volume":"77","author":"Weir","year":"2022","journal-title":"J Gerontol Ser A"},{"issue":"4","key":"10.1016\/j.pec.2025.109432_bib18","first-page":"659","article-title":"Medication regimen complexity in adults and the elderly in a primary healthcare setting: determination of high and low complexities","volume":"13","author":"Ferreira","year":"2015","journal-title":"Pharm Pract"},{"issue":"9","key":"10.1016\/j.pec.2025.109432_bib19","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1345\/aph.1D479","article-title":"Development and validation of the medication regimen complexity index","volume":"38","author":"George","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.pec.2025.109432_bib20","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.2147\/PPA.S501049","article-title":"Deprescribing 5-aminosalicytes in patients with ulcerative colitis on concomitant advanced therapy: a qualitative analysis","author":"Cruchelow","year":"2025","journal-title":"Patient Prefer Adherence"},{"issue":"11","key":"10.1016\/j.pec.2025.109432_bib21","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1093\/rheumatology\/key205","article-title":"The patient perspective on biologic DMARD dose reduction in rheumatoid arthritis: a mixed methods study","volume":"57","author":"Verhoef","year":"2018","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.pec.2025.109432_bib22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/msc.1367","article-title":"Dose reduction of biologic therapy in inflammatory arthritis: a qualitative study of patients' perceptions and needs","volume":"17","author":"Hewlett","year":"2019","journal-title":"Musculoskelet care"},{"issue":"4","key":"10.1016\/j.pec.2025.109432_bib23","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/acr.23301","article-title":"Rheumatoid arthritis patients\u2019 motivations for accepting or resisting disease-modifying antirheumatic drug treatment regimens","volume":"70","author":"Shaw","year":"2018","journal-title":"Arthritis Care Res"},{"issue":"12","key":"10.1016\/j.pec.2025.109432_bib24","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.3899\/jrheum.171339","article-title":"Association of medication beliefs, self-efficacy, and adherence in a diverse cohort of adults with rheumatoid arthritis","volume":"45","author":"McCulley","year":"2018","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.pec.2025.109432_bib25","article-title":"Older adults\u2019 attitudes toward deprescribing in 14 countries","volume":"8","author":"L\u00fcthold","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.pec.2025.109432_bib26","first-page":"28","article-title":"What do clinical practice guidelines say about deprescribing? A scoping review","volume":"34","author":"Langford","year":"2025","journal-title":"BMJ Qual Saf"},{"key":"10.1016\/j.pec.2025.109432_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h1389","article-title":"Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial","volume":"350","author":"van Herwaarden","year":"2015","journal-title":"bmj"}],"container-title":["Patient Education and Counseling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738399125007992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738399125007992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T15:57:58Z","timestamp":1773849478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738399125007992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":27,"alternative-id":["S0738399125007992"],"URL":"https:\/\/doi.org\/10.1016\/j.pec.2025.109432","relation":{},"ISSN":["0738-3991"],"issn-type":[{"value":"0738-3991","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patients\u2019 attitudes towards deprescribing disease modifying anti-rheumatic drugs in rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Patient Education and Counseling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pec.2025.109432","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109432"}}